FDA approves new painkiller designed to avoid opioid addiction risk
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
Indiana Capital Chronicle1h
Going to court is never fun, but here’s why we sued the state
The Indiana Capital Chronicle sued the Indiana Department of Correction last week — a move we don’t take lightly.
Democrats challenge Trump on drug prices after executive order
House Democrats press the Trump administration for clarity on how the president's order rescinding Biden's drug cost ...
AbbVie forecasts 2025 profit above estimates, driven by newer immunology drugs
AbbVie forecast 2025 profit above estimates on Friday, as strong sales of its newer immunology drugs Skyrizi and Rinvoq make up for a steep decline in those of Humira, its flagship rheumatoid ...
Hays Post2h
Local pharmacies closings across state for advocacy day; learn why, see where
Independent pharmacies across Kansas will close on Wednesday, Feb.5, for a day of advocacy to raise awareness of what they ...
Europe to review safety data for Eisai-Biogen Alzheimer's drug
The European Commission has requested its medicines regulator to consider safety information on Eisai and Biogen's ...
NVS Earnings: Entresto Drugmaker Novartis Tops Estimates as Patent Expiry Looms
Swiss pharmaceutical giant Novartis (NVS) on Friday reported forecast-beating quarterly sales as its clutch of heart failure to breast cancer ...